Abstract
The emergence of antimicrobial resistance and increase in side effects of antibiotic therapy is actual problem in pediatrics. Bacteriophages are one of the most promising alternatives to antibiotics for clinical use. The aim of the work was to define the therapy effect of phages administered per os in children with diarrheal diseases. An open observation controlled clinical trial was performed. 52 children aged from 3 to 15 years with diarrheal diseases of bacterial etiology were monitored, as outpatients. According to our clinical trial results (preliminary results) Bacteriophage therapy with SEPTAPHAGE improves clinical course of diarrhea in outpatients aged from 3 to 15 years. Thus, Bacteriophage therapy seems to be effective and safe antimicrobial therapy.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
